Org. Lett. 2026, 28 (31), 10015-10021
DOI: 10.1021/acs.orglett.6c02697
Teoh Y. S.; Lee S.; Meares P. W.; McManus E. M.; Or K. L.; Gevirtzman V.; Mykhailiuk P. K.; Krische M. J.
Using the inexpensive, air-stable ruthenium catalyst derived from RuHCl(CO)(PPh3)3 and the achiral ligands Cy-BIPHEP or dCypb, acetylenic bicyclooctyl, azabicycloheptyl, adamantyl, bicyclopentyl and azabicyclooctyl bioisosteres 2a–2f are conjugated to diverse azines and azoles 1a–1t via Csp2–Csp3 bond formation. Using chiral ruthenium catalysts modified by (S)-Cy-SEGPHOS or (R)-Cy-BINAP, high levels of enantioselectivity are obtained in reactions of azines. Late-stage C–H functionalization of the B(Epin) derivative of bortezomib (Velcade) and studies corroborating the reaction mechanism are described.